Table 4. Complication and short-term mortality rates.
| Characteristic | Age > 80 years (group A) 13 Pts (%) | Age < 80 years (group B) 356 Pts (%) | Age < 80 years (group A vs B) p -Value | Matched a age <80 years (group C) 13 Pts (%) | Matched a age <80 years (group A vs C) p -Value |
|---|---|---|---|---|---|
| Early wound complications | 3 (23.1) | 29 (9.4) | > 0.999 | 3 (25) | > 0.999 |
| Late wound complications | 0 (0) | 41 (12.8) | 0.397 | 0 (0) | > 0.999 |
| Early CNS complications | 1(7.7) | 35 (11.3) | 0.375 | 1 (0) | > 0.999 |
| Late CNS complications | 0 (0) | 24 (7.6) | > 0.999 | 0 (0) | > 0.999 |
| Early systemic complications | 1 (7.7) | 34 (10.9) | 0.623 | 4 (30.8) | 0.083 |
| Late systemic complications | 1 (7.7) | 2 (0.7) | > 0.999 | 0 (0) | > 0.999 |
| Early orbital complications | 0 (0) | 7 (2.3) | > 0.999 | 0 (0) | > 0.999 |
| Late orbital complications | 1 (7.7) | 23 (7.4) | 0.546 | 0 (0) | 0.317 |
| 30-day mortality | 0 (0) | 4 (1.1) | > 0.999 | 3 (23.1) | 0.046 |
Abbreviations: CNS, central nervous system; Pts, patients; Yrs, years.
a
Group C—Thirteen patients matched by gender, major and minor comorbidities, preoperative treatment (surgery/chemoradiotherapy), status of the disease (primary vs recurrence/persistence), surgical intracranial or dural extension, benign or malignant pathology, and site of skull base involvement (lateral/anterior).